XOMA Completes Enrollment in Phase 2 Proof-of-Concept Gevokizumab Trial in Patients With Erosive Osteoarthritis of the Hand Jul 22, 2013 8:00am EDT
XOMA's Development Partner SERVIER Launches Proof-of-Concept Clinical Program for Gevokizumab Jun 25, 2013 9:00am EDT
XOMA Initiates Pilot Trial Studying Gevokizumab in Patients With Pyoderma Gangrenosum Jun 13, 2013 9:00am EDT
XOMA Highlights Recent Achievements and Reports Financial Results for First Quarter 2013 May 08, 2013 4:01pm EDT
XOMA to Announce First Quarter 2013 Financial Results and Host Webcast on May 8 Apr 25, 2013 8:01am EDT
XOMA Announces Clinical Study Investigating Gevokizumab in Patients With Non-Infectious Anterior Scleritis Has Opened for Enrollment at the National Eye Institute Apr 10, 2013 8:00am EDT
XOMA Appoints Tom Klein to Newly Created Position of Chief Commercial Officer Mar 18, 2013 1:00pm EDT
